Intrathecal 2-chloroprocaine for lower limb outpatient surgery: A prospective, randomized, double-blind, clinical evaluation

Anesthesia and Analgesia

Volumn 103, Issue 1, 2006, Pages 234-238

  Casati, Andrea ^a,b   Danelli, Giorgio ^a   Berti, Marco ^a   Fioro, Augusto ^a   Fanelli, Andrea ^a   Benassi, Cristina ^a   Petronella, Gioacchino ^a   Fanelli, Guido ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ATROPINE; CHLOROPROCAINE; LOCAL ANESTHETIC AGENT; TRAMADOL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; AMBULATORY SURGERY; ANESTHETIC RECOVERY; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; EVALUATION; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MALE; MOBILIZATION; NAUSEA; NEUROLOGIC DISEASE; OPERATION DURATION; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA; VOMITING;

EID: 33745842966     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000221441.44387.82     Document Type: Article

References (28)

1. Schnider M, Ettlin T, Kaufmann M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993;76:1154-7.
2. Hampl K, Schneider M, Umenhofer W, Drewe J. Transient neurologic symptoms after spinal anesthesia. Anesth Analg 1995;81:1148-53.
3. Pollock JE, Neal JM, Stephenson CA, Wiley CE. Prospective study of the incidence of transient radicular irritation in patients undergoing spinal anesthesia. Anesthesiology 1996;84:1361-7.
4. Freedman JM, Drasner K, Jaskela MC, et al. Transient neurologic symptoms after spinal anesthesia: an epidemiologic study of 1863 patients. Anesthesiology 1998;89:633-41.
5. Zaric D, Christiansen C, Pace NL, Punjasawadwong Y. Transient neurologic symptoms after spinal anesthesia with lidocaine versus other local anesthetics: a systematic review of randomized, controlled trials. Anesth Analg 2005;100:1811-6.
6. Liu SS, Ware PD, Allen HW, et al. Dose-response characteristics of spinal bupivacaine in volunteers: clinical implications for ambulatory anesthesia. Anesthesiology 1996;85:729-36.
7. Ben-David B, Solomon E, Admoni H, et al. Intrathecal fentanyl with small-dose dilute bupivacaine: better anestesia without prolonging recovery. Anesth Analg 1997;85:560-5.
8. Foldes FF, McNAll PG. 2-chloroprocaine: a new local anesthetic agent. Anesthesiology 1952;13:287-96.
9. Ravindran RS, Bond VK, Tash MD, et al. Prolonged neural blockade following regional anesthesia with 2-chloroprocaine. Anesth Analg 1980;59:447-51.
10. Reisner LS, Hochman BN, Plumer MH. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine. Anesth Analg 1980;59:452-4.
11. Moore DC, Spierdijk J, van Kleef JD, et al. Chloroprocaine toxicity: four additional cases. Anesth Analg 1982;61:158-9.
12. Gissen AJ, Datta S, Lambert D. The chloroprocaine controversy II: is chloroprocaine neurotoxic? Reg Anesth 1984;9:135-45.
13. Wang BC, Hillman DE, Spiekholz NI. Chronic neurological deficits and nescaine-CE: an effect of the anesthetic 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 1984;63:445-7.
14. Taniguchi M, Bollen AW, Drasner K. Sodium bisulfite: scapegoat for chloroprocaine neurotoxicity? Anesthesiology 2004;100:85-91.
15. Drasner K. Chloroprocaine spinal anesthesia: back to the future? Anesth Analg 2005;100:549-52.
16. Gunnison AF, Bresnahan CA, Palmes ED. Comparative sulfite metabolism in the rat, rabbit, and rhesus monkey. Toxicol Appl Pharmacol 1977;42:99-109.
17. Kouri ME, Kopacz DJ. Spinal 2-choloroprocaine: a comparison with lidocaine in volunteers. Anesth Analg 2004;98:75-80.
18. Smith KN, Kopacz DJ, McDonald SB. Spinal 2-chloroprocaine: a dose-ranging study and the effect of added epinephrine. Anesth Analg 2004;98:81-8.
19. Kopacz DJ. Spinal chloroprocaine: minimum effective dose. Reg Anesth Pain Med 2005;30:36-42.
20. Yoos JR, Kopacz DJ. Spinal 2-chloroprocaine for surgery: an initial 10-month experience. Anesth Analg 2004;99:553-8.
21. Timo P. Four years experience with 1% chloroprocaine for spinal anesthesia in ambulatory anesthesia. Reg Anesth Pain Med 2005;30:A160.
22. Fanelli G, Borghi B, Casati A, et al. Unilateral bupivacaine spinal anesthesia for outpatient knee arthroscopy. Italian Study Group on Unilateral Spinal Anesthesia. Can J Anaesth 2000;47:746-51.
23. Browner WS, Black D, Newman B, Hulley SB. Estimating sample size and power. In: Hulley SB, Cummings SR, eds. Designing clinical research: an epidemiologic approach. Baltimore: Williams & Wilkins 1988;139-50.
24. Vath JS, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added fentanyl. Anesth Analg 2004;98:89-94.
25. Davis BR, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added clonidine. Anesth Analg 2005;100:559-65.
26. Pavlin DJ, Pavlin EG, Gunn HC, et al. Voiding in patients managed with or without ultrasound monitoring of bladder volume after outpatient surgery. Anesth Analg 1999;89:90-7.
27. Mulroy MF, Salinas FV, Larkin L, Polissar NL. Ambulatory surgery patients may be discharged before voiding after short-acting spinal and epidural anesthesia. Anesthesiology 2002;97:315-9.
28. Zhang X, Vincent AS, Halliwell B, Wong KP. A mechanism of sulfite neurotoxicity. Direct inhibition of glutamate dehydrogenase. J Biol Chem 2004;279:43035-45.